147 related articles for article (PubMed ID: 36633319)
21. Fusobacteria modulate oral carcinogenesis and promote cancer progression.
Harrandah AM; Chukkapalli SS; Bhattacharyya I; Progulske-Fox A; Chan EKL
J Oral Microbiol; 2020 Nov; 13(1):1849493. PubMed ID: 33391626
[No Abstract] [Full Text] [Related]
22. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
23.
Kim HS; Kim CG; Kim WK; Kim KA; Yoo J; Min BS; Paik S; Shin SJ; Lee H; Lee K; Kim H; Shin EC; Kim TM; Ahn JB
Front Cell Infect Microbiol; 2023; 13():1101291. PubMed ID: 36960042
[TBL] [Abstract][Full Text] [Related]
24. Fusobacterium nucleatum and cancer.
Alon-Maimon T; Mandelboim O; Bachrach G
Periodontol 2000; 2022 Jun; 89(1):166-180. PubMed ID: 35244982
[TBL] [Abstract][Full Text] [Related]
25. Role of oral microbiome in oral oncogenesis, tumor progression, and metastasis.
Li R; Xiao L; Gong T; Liu J; Li Y; Zhou X; Li Y; Zheng X
Mol Oral Microbiol; 2023 Feb; 38(1):9-22. PubMed ID: 36420924
[TBL] [Abstract][Full Text] [Related]
26. Who is who in oral cancer?
Zhang WL; Wang SS; Wang HF; Tang YJ; Tang YL; Liang XH
Exp Cell Res; 2019 Nov; 384(2):111634. PubMed ID: 31541617
[TBL] [Abstract][Full Text] [Related]
27. The classification of fusobacteria from the human mouth.
BAIRD-PARKER AC
J Gen Microbiol; 1960 Apr; 22():458-69. PubMed ID: 13795919
[No Abstract] [Full Text] [Related]
28. Involvement of
He Z; Tian W; Wei Q; Xu J
Front Immunol; 2022; 13():968649. PubMed ID: 36059542
[No Abstract] [Full Text] [Related]
29. Biofilm and Cancer: Interactions and Future Directions for Cancer Therapy.
Choi E; Murray B; Choi S
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629016
[TBL] [Abstract][Full Text] [Related]
30. Intraoral populations of Fusobacteria, lactobacilli and streptococci.
ONISI M; KONDO W; TAKIZAWA S
Jpn J Microbiol; 1961 Jan; 5():117-27. PubMed ID: 14482043
[No Abstract] [Full Text] [Related]
31. A selective medium for oral fusobacteria.
DISRAELY MN; OMATA RR
J Bacteriol; 1956 Nov; 72(5):677-80. PubMed ID: 13376514
[No Abstract] [Full Text] [Related]
32. Role of Fusobacteria in the serrated pathway of colorectal carcinogenesis.
Park CH; Han DS; Oh YH; Lee AR; Lee YR; Eun CS
Sci Rep; 2016 Apr; 6():25271. PubMed ID: 27125587
[TBL] [Abstract][Full Text] [Related]
33. A systematic study of Fusobacterium and Necrobacterium (i. e. Actinomyces necrophorus, Nekrosebacillus Bang) as to their biological relationships and proposal of a new and adequate name for the latter.
LAHELLE O; THJOTTA T
Acta Pathol Microbiol Scand; 1945; 22(3):310-22. PubMed ID: 21021824
[No Abstract] [Full Text] [Related]
34. The 'Danse Macabre'-Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes.
Hadjigol S; Shah BA; O'Brien-Simpson NM
Front Immunol; 2022; 13():894021. PubMed ID: 35784290
[TBL] [Abstract][Full Text] [Related]
35. "Messieurs, c'est les microbes qui auront le dernier mot": Gentlemen, it is the microbes who have the last word (Louis Pasteur)-
Gur C; Mandelboim O; Bachrach G
Oncoimmunology; 2015 Sep; 4(9):e1038690. PubMed ID: 26405611
[No Abstract] [Full Text] [Related]
36. Helicobacter pylori adheres selectively to Fusobacterium spp.
Andersen RN; Ganeshkumar N; Kolenbrander PE
Oral Microbiol Immunol; 1998 Feb; 13(1):51-4. PubMed ID: 9573823
[TBL] [Abstract][Full Text] [Related]
37. Isolation of fusobacteria from the oral cavities of malnourished Nigerian children living in agricultural and herding villages.
Falkler WA; Enwonwu CO; Ewell AJ; Idigbe EO
Oral Dis; 2000 Mar; 6(2):103-5. PubMed ID: 10702787
[TBL] [Abstract][Full Text] [Related]
38. Microenvironment in Oral Potentially Malignant Disorders: Multi-Dimensional Characteristics and Mechanisms of Carcinogenesis.
Deng S; Wang S; Shi X; Zhou H
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012205
[TBL] [Abstract][Full Text] [Related]
39. Cellular fatty acid and soluble protein profiles of oral fusobacteria.
Calhoon DA; Mayberry WR; Slots J
J Dent Res; 1983 Dec; 62(12):1181-5. PubMed ID: 6581193
[TBL] [Abstract][Full Text] [Related]
40. Targeting pancreatic cancer immune evasion by inhibiting histone deacetylases.
Sim W; Lim WM; Hii LW; Leong CO; Mai CW
World J Gastroenterol; 2022 May; 28(18):1934-1945. PubMed ID: 35664961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
